Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Maxcyte Inc
(NQ:
MXCT
)
4.540
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Maxcyte Inc
< Previous
1
2
3
Next >
Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 11, 2023
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 109.8% to $1.06 after reporting a rise in Q1 sales.
Via
Benzinga
Disney, Sonos, Desktop Metal And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
May 11, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Sonos, Inc. (NASDAQ: SONO) shares dipped 25.2% to $15.82 in pre-market...
Via
Benzinga
Recap: MaxCyte Q1 Earnings
May 10, 2023
Via
Benzinga
Looking Into MaxCyte's Return On Capital Employed
March 16, 2023
Via
Benzinga
MaxCyte's Earnings: A Preview
March 14, 2023
Via
Benzinga
7 Small-Cap Biotech Stocks with Massive Potential
April 27, 2023
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.
Via
InvestorPlace
Around $1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
March 31, 2023
The Dow Jones closed higher by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or ...
Via
Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
MaxCyte Earnings Perspective: Return On Capital Employed
December 14, 2022
Via
Benzinga
7 Must-Buy Penny Stocks to Add to Your Portfolio in 2023
February 22, 2023
For those that want to take a journey on the wild side of the market, these penny stocks may offer significant upside rewards.
Via
InvestorPlace
7 Hot Stocks to Book Profits In Before 2023
December 19, 2022
With major macroeconomic headwinds appearing on the horizon, it’s time for investors to consider the hot stocks to book profits in.
Via
InvestorPlace
Earnings Outlook For MaxCyte
November 08, 2022
MaxCyte (NASDAQ:MXCT) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that MaxCyte will...
Via
Benzinga
MaxCyte Inks Platform License With Vertex For Gene-Editing Program For Rare Blood Disorders
September 28, 2022
MaxCyte Inc (NASDAQ: MXCT) has signed a
Via
Benzinga
Recap: MaxCyte Q2 Earnings
August 10, 2022
MaxCyte (NASDAQ:MXCT) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings MaxCyte reported in-line EPS of...
Via
Benzinga
A Preview Of MaxCyte's Earnings
August 09, 2022
MaxCyte (NASDAQ:MXCT) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Analysts estimate that MaxCyte will...
Via
Benzinga
MaxCyte Expects Q1 Sales To Beat Expectations, CFO Resigns
April 13, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...
Via
Benzinga
Earnings Scheduled For May 9, 2022
May 09, 2022
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Via
Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
April 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal
Via
Benzinga
MaxCyte's Return On Capital Employed Insights
March 23, 2022
Benzinga Pro data, MaxCyte (NASDAQ:MXCT) reported Q4 sales of $10.15 million. Earnings fell to a loss of $4.87 million, resulting in a 81.85% decrease from last quarter. MaxCyte...
Via
Benzinga
Earnings Scheduled For March 22, 2022
March 22, 2022
Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.18 per share on revenue of $338.69 million. • HUYA (...
Via
Benzinga
11 Health Care Stocks Moving In Monday's Intraday Session
January 24, 2022
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares rose 35.6% to $2.17 during Monday's regular session. The current volume of 5.6 million shares is 531.8% of Aridis...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 23, 2021
Gainers Pasithea Therapeutics (NASDAQ:KTTA
Via
Benzinga
MaxCyte, Inc. (MXCT) Q3 2021 Earnings Call Transcript
November 12, 2021
MXCT earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's Intraday Session
November 11, 2021
Gainers Liquidia (NASDAQ:LQDA) stock inc...
Via
Benzinga
91 Biggest Movers From Yesterday
November 12, 2021
Gainers NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 01, 2021
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's pre-market session. The company's market cap stands at $27.1...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 01, 2021
Welcome back, investor! We're starting off the trading week with a breakdown of the biggest pre-market stock movers for Monday!
Via
InvestorPlace
28 Stocks Moving In Friday's Mid-Day Session
October 08, 2021
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 08, 2021
Gainers ChemoCentryx (NASDAQ:CCXI) shares rose 77.65% to $34.82 during Friday's pre-market session. The company's market cap stands at $2.4 billion. eFFECTOR...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.